Algae Producer Contract Biotics to Add Six Additional Acres to Its Operations



Estimated read time: 3-4 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

[STK]

[IN] SPM HEA

[SU] CXP

-- WITH PHOTO -- TO BUSINESS, AND HEALTH EDITORS:

Valensa Supplier Launches Major Expansion of Natural Astaxanthin

Biomass Capacity

ORLANDO, Fla. and LA JOLLA, Calif., March 7, 2014 /PRNewswire/ --

Valensa International and Contract Biotics announced today that

Contract Biotics has started construction of an additional six acres

of algae production units at the company's San Diego County facility.

Slated to come on-line in the fall of this year, the expansion will

more than triple Contract Biotics' current biomass production and thus

play a crucial role in helping Valensa meet the market demand for its

line of formulated, condition-specific Astaxanthin-based products.

Contract Biotics is a U.S. based wholesale producer of a wide variety

of high quality algae biomass. The California facility is unique

because it employs a hybrid greenhouse technology to protect the

production ponds from outside contamination unlike other producers who

employ "open" ponds. The use of U.S.-sourced biomass combined with its

Florida-based organic certified extraction facilities makes Valensa

the only "Made in America" Astaxanthin supplier on the market today.

Logo - http://photos.prnewswire.com/prnh/20140307/PH78998LOGO-a Logo -

http://photos.prnewswire.com/prnh/20140307/PH78998LOGO-b

Dr. Rudi E. Moerck, President & CEO of Valensa, stated, "The market

supply of Astaxanthin continues to lag behind demand, in part due to

the worldwide success of Valensa's patented joint health products

containing this potent carotenoid. Contract Biotics has proven itself

as an algae biomass producer, and we are extremely pleased that

Valensa was able to help support them by making a direct investment in

the company. This investment will allow Contract Biotics achieve the

growth to help Valensa fuel its strategic initiatives."

In regard to the expansion, Contract Biotics CEO Ken Reynolds stated:

"The interest we have received in funding our most recent expansion

round was substantial, and it was a very positive validation of our

overall approach and success as a producer. We anticipate that this

will be the first of many additions to our production capabilities,"

he said.

One of the most exciting nutritional ingredients on the market

As one of the most powerful known fat-soluble antioxidants,

Astaxanthin has long been recognized for its ability to protect

against cell damage caused by oxidative stress. There has been an

added surge in demand for Astaxanthin in recent years, with health

experts such as Dr. Oz and Dr. Mercola publicly promoting the benefits

of Astaxanthin-based supplements. It is commonly produced through the

cultivation and harvesting of a naturally-occurring variety of

freshwater micro-algae. However, the specific species for this purpose

is extremely difficult to cultivate on a commercial scale.

"Contract Biotics is already in a great position to become one of the

best new Astaxanthin biomass producers in the world," said Dr. Moerck.

"As a strategic partner and a key investor in their new facility, we

look forward to working closely with the company to increase

efficiency and streamline processes with the goal of their becoming an

industry leader in terms of output volume and lower production costs,"

he added.

For further information contact: Dr. Rudi Moerck, President & CEO

Voice: 210-632-0695 www.valensa.com

Read more news from Valensa.

SOURCE Valensa

-0- 03/07/2014

/Photo: http://photos.prnewswire.com/prnh/20140307/PH78998LOGO-a

http://photos.prnewswire.com/prnh/20140307/PH78998LOGO-b

PRN Photo Desk, photodesk@prnewswire.com

/Web Site: http://www.valensa.com

CO: Valensa; Contract Biotics

ST: California Florida

IN: SPM HEA

SU: CXP

PRN

-- PH78998 --

0000 03/07/2014 13:29:00 EDT http://www.prnewswire.com

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
The Associated Press

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast